Skip to main content

Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth quarter-over-quarter October 2025 ending cash and cash equivalents of over $100 million; ended Q3 2025 with $85.0 million in cash and cash equivalents after closing of $57.5 million public offering in August 2025, with additional $29.8 million gross proceeds from usage of at-the-market (ATM) offering facility in October 2025 Announced U.S. IND clearance and alignment with U.S. FDA on pivotal clinical program for VYD2311, a vaccine-alternative antibody to prevent COVID REVOLUTION, Invivyd’s development program for VYD2311, comprises the DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials, which are...

Continue reading

Brookfield Business Partners Reports Third Quarter 2025 Results

BROOKFIELD, NEWS, Nov. 06, 2025 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) announced today financial results for the quarter ended September 30, 2025. “We made excellent progress in our business over the past few months, completing the acquisition of a Canadian residential and multi-family mortgage lender, generating $180 million from our capital recycling initiatives and announcing the simplification of our corporate structure,” said Anuj Ranjan, CEO of Brookfield Business Partners. “Our plan to convert into a single listed corporation has been well received by our investors and continuing to execute on our strategy should support continued growth in the intrinsic value of our business.”  Three Months EndedSeptember 30,   Nine Months EndedSeptember 30,  US$ millions (except per unit...

Continue reading

OLAPLEX Reports Third Quarter 2025 Results

NEW YORK, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced financial results for the third quarter ended September 30, 2025. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: “We are pleased with our third quarter results that reflect investments in sales and marketing, continued progress in our executional capabilities and the early results of our latest new product introductions. We are reaffirming our annual guidance and remain focused on our Bonds and Beyond strategy for sustainable, profitable long-term growth.” For the third quarter of 2025 compared to the third quarter of 2024:Net sales decreased 3.8% to $114.6 million;By channel:Specialty Retail decreased 13.5% to $36.9 million; Professional increased...

Continue reading

Onity Group Announces Third Quarter 2025 Results

WEST PALM BEACH, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced its third quarter 2025 results and provided a business update. Third Quarter 2025:Net income attributable to common stockholders of $18 million; diluted EPS of $2.03; ROE of 14% Adjusted pre-tax income* of $31 million, resulting in annualized adjusted ROE* of 25% Book value per share improved to $62 as of September 30, 2025, up $2.71 YoY Originations volume of $12 billion, up 39% YoY, exceeding industry growth rate Average servicing UPB of $312 billion, up $7 billion YoY2025 Outlook:Expect to exceed 2025 adjusted ROE* guidance range of 16% – 18% Expect to release a significant portion of $180 million deferred tax asset (DTA) valuation allowance as of December 31, 2024, by year-end 2025; third...

Continue reading

Playtika Holding Corp. Reports Q3 2025 Financial Results

Revenue of $674.6 million and Direct-to-Consumer (“DTC”) Revenue of $209.3 millionRevenue Decreased (3.1)% Sequentially and Increased 8.7% Year Over Year DTC Platforms Revenue Increased 19.0% Sequentially and 20.0% Year Over Year HERZLIYA, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) —  Playtika Holding Corp. (NASDAQ: PLTK) today released financial results for its third quarter for the period ending September 30, 2025. Financial HighlightsRevenue of $674.6 million decreased (3.1)% sequentially and increased 8.7% year over year. Record DTC platforms revenue of $209.3 million increased 19.0% sequentially and 20.0% year over year. GAAP Net Income of $39.1 million increased 17.8% sequentially and decreased (0.5)% year over year. Adjusted Net Income of $65.8 million increased 912.3% sequentially and 16.3% year over year. Adjusted EBITDA...

Continue reading

Vivid Seats Reports Third Quarter 2025 Results; Announces CEO Transition

Lawrence Fey Appointed Chief Executive Officer Provides 2026 Initial Outlook Driven by Leading Value Proposition & Efficiency Initiatives CHICAGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the third quarter ended September 30, 2025 and announced a leadership transition. Third Quarter 2025 Key Operational and Financial MetricsMarketplace GOV of $618.1 million – down 29% from $871.7 million in Q3 2024 Revenues of $136.4 million – down 27% from $186.6 million in Q3 2024 Net loss of $19.7 million – down $28.9 million from net income of $9.2 million in Q3 2024 Adjusted EBITDA...

Continue reading

Esperion Reports Third Quarter 2025 Financial Results and Provides Business Update

– Q3 2025 Total Revenue Grew 69% Y/Y to $87.3 Million – – Q3 2025 U.S. Net Product Revenue Grew 31% Y/Y to $40.7 Million – – Reached Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 2040 – – Bempedoic Acid Received Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidemias – – Partner Otsuka Received Regulatory Approval and Favorable Preliminary Pricing to Market NEXLETOL in Japan, Which Will Trigger Significant Milestone Payments Upon Final Pricing Approval – – Conference Call and Webcast Today at 8:00 a.m. ET – ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today reported financial results for the third quarter ended September 30, 2025, and...

Continue reading

SYLOGIST Reports Third Quarter 2025 Results

Delivers 12% SaaS revenue growth and 19% Adjusted EBITDA Margin Q3 2025 Financial Highlights  Revenue (in $ millions)  SaaS Subscription Recurring TotalReported Y/Y growth Reported Y/Y growth Reported Y/Y growth$8.3 11.9% $11.4 5.0% $15.9 (4.2)% SaaS ARR up 15% year over year to $33.6 million; Total ARR up 5% year over year to $45.8 million; SaaS NRR of 106%; ARR Bookings of $1.0 million; Total Contract Value of Bookings at $5.9 million; Adjusted EBITDA Margin of 19.3% or $3.1 million; Net income (loss) of $(0.9) million Gross profit margin of 60%; and Recurring revenue at 72% of total revenue.CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, today announced its results for the third quarter...

Continue reading

Arhaus Reports Third Quarter 2025 Financial Results

BOSTON HEIGHTS, Ohio, Nov. 06, 2025 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, reported third quarter 2025 results for the period ended September 30, 2025. Third Quarter 2025 HighlightsNet revenue increased 8.0% to $345 million, compared to the third quarter of 2024 Gross margin increased 8.4% to $133 million, compared to the third quarter of 2024 Selling, general and administrative expenses increased 4.1% to $117 million, compared to the third quarter of 2024 Net and comprehensive income increased 23.1% to $12 million, compared to the third quarter of 2024 Adjusted EBITDA increased 35.2% to $31 million, compared to the third quarter of 2024 Comparable growth(1) of 4.1%John Reed, Co-Founder and Chief...

Continue reading

Lamar Advertising Company Announces Third Quarter Ended September 30, 2025 Operating Results

Three Month ResultsNet revenues were $585.5 million Net income was $144.1 million Adjusted EBITDA was $280.8 millionNine Month ResultsNet revenues were $1.67 billion Net income was $438.3 million Adjusted EBITDA was $769.4 millionBATON ROUGE, La., Nov. 06, 2025 (GLOBE NEWSWIRE) — Lamar Advertising Company (the “Company” or “Lamar”) (Nasdaq: LAMR), a leading owner and operator of outdoor advertising and logo sign displays, announces the Company’s operating results for the third quarter ended September 30, 2025. “We delivered solid results in the third quarter, with an impressive uptick in national sales and consolidated year-over-year revenue growth improving to 2.9% on an acquisition-adjusted basis. In addition, we like the strength we are seeing in the holiday season and our momentum going into next year,”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.